IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?. (2021). Mediterranean Journal of Hematology and Infectious Diseases, 13(1), e2021062. https://doi.org/10.4084/MJHID.2021.062